Unibest

Pharmaceutical intermediates

Parecoxib sodium Intermediates

1 pharmaceutical intermediate for Parecoxib sodium. Indication: Pain, Postoperative.

提交项目All intermediates

About Parecoxib sodium

Originator
Pfizer Inc
Indication
Pain, Postoperative
Approved Date
03/22/2022

Available intermediates

1 intermediate currently listed for Parecoxib sodium. Request specifications, documentation or a quotation for any item below.

Parecoxib sodium intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
5-Methyl-3,4-diphenylisoxazole37928-17-9//

Other programs under P

PacritinibPalbociclibParicalcitolPaxlovidPazopanib HydrochloridePeficitinib HydrobromidePemafibratePeramivir

Building toward Parecoxib sodium?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →